Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.


European Society of Cardiology recommends (rivaroxaban) XARELTO® 2.5 mg plus acetylsalicylic acid for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromes
Bayer completes sale of iconic Coppertone™ brand to Beiersdorf
Health Canada approves VITRAKVI® (larotrectinib), the first tumour agnostic cancer treatment for advanced solid tumours harbouring an NTRK gene fusion
Yellow Wood Partners to acquire iconic Dr. Scholl’s™ brand from Bayer
Beiersdorf to acquire iconic Coppertone™ brand from Bayer
Delaro fungicide now registered for cereals
Bayer Fund to provide nearly $100,000 in scholarships to eligible Canadian high school students in 2019
New Single-dose Treatment for Canine Otitis Externa Launches in Canada